Chronic interstitial nephritis in an HIV type-1-infected patient receiving ritonavir-boosted atazanavir

Antiviral Therapy

Volumn 16, Issue 1, 2011, Pages 119-121

  Viglietti, Denis ^a   Verine, Jérôme ^a   De Castro, Nathalie ^a   Scemla, Anne ^a   Daudon, Michel ^b   Glotz, Denis ^a   Pillebout, Evangeline ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ATAZANAVIR PLUS RITONAVIR; DIDANOSINE; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; PREDNISONE; ZIDOVUDINE;

ADULT; ANEMIA; ARTICLE; CASE REPORT; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; CRYSTAL; DRUG WITHDRAWAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HYPERTRIGLYCERIDEMIA; INTERSTITIAL NEPHRITIS; LEUKOCYTURIA; LEUKOPENIA; MALE; NEUROTOXICITY; PRIORITY JOURNAL; STEROID THERAPY; SYMPTOM;

AFRICA, NORTHERN; CRYSTALLIZATION; DRUG THERAPY, COMBINATION; FRANCE; GRANULOMATOUS DISEASE, CHRONIC; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; MALE; MIDDLE AGED; NEPHRITIS, INTERSTITIAL; OLIGOPEPTIDES; PYRIDINES; RITONAVIR;

EID: 79951489628     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: 10.3851/IMP1700     Document Type: Article

References (9)

1. Chang HR, Pella PM. Atazanavir urolithiasis. N Engl J Med 2006; 355:2158-2159.
2. Couzigou C, Daudon M, Meynard JL, et al. Urolithiasis in HIV-positive patients treated with atazanavir. Clin Infect Dis 2007; 45:e105-e108. (Pubitemid 47580370)
3. Chan-Tack KM, Truffa MM, Struble KA, Birnkrant DB. Atazanavir associated nephrolithiasis: cases from the US Food and Drug Administration's Adverse Event Reporting System. AIDS 2007; 21:1215-1218. (Pubitemid 46763296)
4. Brewster UC, Perazella MA. Acute interstitial nephritis associated with atazanavir, a new protease inhibitor. Am J Kidney Dis 2004; 44:e81-e84. (Pubitemid 39445931)
5. Izzedine H. M'rad MB, Bardier A, Daudon M, Salmon D. Atazanavir crystal nephropathy. AIDS 2007; 21:2357-2358.
6. Kirk O, Mocroft A, Reiss P, et al. Chronic kidney disease and exposure to ART in a large cohort with long-term follow-up: the EuroSIDA study. 17th Conference on Retroviruses and Opportunistic Infections. 16-19 February 2010, San Francisco, CA, USA. Abstract 107LB.
7. Schmid S, Opravil M, Moddel M, et al. Acute interstitial nephritis of HIV-positive patients under atazanavir and tenofovir therapy in a retrospective analysis of kidney biopsies. Virchows Arch 2007; 450:665-670. (Pubitemid 46986233)
8. Cervero M, Navas E, Agud JL, Garcia-Benaya E, Mon C. Atazanavir-related renal insufficiency without concurrent tenofovir. Enferm Infecc Microbiol Clin 2009; 27:489-490.
9. Reyataz (atazanavir sulfate). Package Insert 2006. Bristol-Myers Squibb Co., Princeton, NJ, USA.